Literature DB >> 32505716

Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitis.

Roberto Padoan1, Fulvia Chieco Bianchi2, Maria Rita Marchi2, Diego Cazzador3, Mara Felicetti1, Enzo Emanuelli4, Andrea Vianello2, Piero Nicolai4, Andrea Doria1, Franco Schiavon5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32505716     DOI： 10.1016/j.jaip.2020.05.033

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  6 in total

Review 1.  A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis.

Authors:  Haruki Koike; Ryoji Nishi; Satoru Yagi; Soma Furukawa; Yuki Fukami; Masahiro Iijima; Masahisa Katsuno
Journal:  Adv Ther       Date:  2022-09-24       Impact factor: 4.070

2.  Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis.

Authors:  Alexandra M Nanzer; Jaideep Dhariwal; Joanne Kavanagh; Andrew Hearn; Mariana Fernandes; Louise Thomson; Cris Roxas; Linda Green; Grainne D'Ancona; Sangita Agarwal; Brian D Kent; David J Jackson
Journal:  ERJ Open Res       Date:  2020-11-10

Review 3.  Advances in cutaneous vasculitis research and clinical care.

Authors:  Avrom Caplan; Robert G Micheletti
Journal:  Ann Transl Med       Date:  2021-03

Review 4.  Perspectives on the Efficacy of Benralizumab for Treatment of Eosinophilic Granulomatosis With Polyangiitis.

Authors:  Yasuhiko Koga; Haruka Aoki-Saito; Yosuke Kamide; Makiko Sato; Hiroaki Tsurumaki; Masakiyo Yatomi; Tamotsu Ishizuka; Takeshi Hisada
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

Review 5.  Eosinophilic airway diseases: basic science, clinical manifestations and future challenges.

Authors:  Christer Janson; Leif Bjermer; Lauri Lehtimäki; Hannu Kankaanranta; Jussi Karjalainen; Alan Altraja; Valentyna Yasinska; Bernt Aarli; Madeleine Rådinger; Johan Hellgren; Magnus Lofdahl; Peter H Howarth; Celeste Porsbjerg
Journal:  Eur Clin Respir J       Date:  2022-03-02

6.  Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab.

Authors:  Francesco Menzella; Carla Galeone; Giulia Ghidoni; Patrizia Ruggiero; Silvia Capobelli; Anna Simonazzi; Chiara Catellani; Chiara Scelfo; Francesco Livrieri; Nicola Facciolongo
Journal:  Multidiscip Respir Med       Date:  2021-06-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.